This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
|01/28/16||Quest Diagnostics Reports Fourth Quarter And Full Year 2015 Financial Results; Provides Guidance For Full Year 2016; Increases Dividend 5% To $0.40 Per Quarter|
|-- Full year revenues grew 2% on an equivalent basis and 0.8% on a reported basis
-- Full year adjusted diluted EPS excluding amortization of $4.77, up 6% versus prior year
-- Full year reported diluted EPS of $4.87, up 29% versus prior year
-- Fourth quarter revenues grew 0.6% on an equivalent basis versus 2014; down 1.8% on a reported basis versus 2014
-- Fourth quarter adjusted diluted EPS excluding amortization of $1.19, up 0.8% versus prior year
-- Fourth quarter reported dil... |
|01/25/16||Quest Diagnostics Expands Dako's PD-L1 IHC 28-8 Complementary Test to Include Melanoma|
|Third offering in Quest's precision medicine menu for oncology immunotherapies
MADISON, N.J., Jan. 25, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it will offer clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx qualitative test from Dako, an Agilent Technologies company. Earlier today, Dako announced the U.S. Food and Drug Administration (FDA) approved the complementary in vitro diagnostic te... |
|01/15/16||Quest Diagnostics To Release Fourth Quarter And Full Year 2015 Financial Results On January 28|
|MADISON, N.J., Jan. 15, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2015 results on Thursday, January 28, 2016, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.
The conference call can be accessed in listen-only mode by dialing 415-228-4961, passcode 3214469.... |
|01/04/16||Quest Diagnostics To Speak At The 34th Annual J.P. Morgan Healthcare Conference|
|MADISON, N.J., Jan. 4, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco. Steve Rusckowski, the company's President and CEO, will discuss the company's vision, goals and five point strategy. The presentation is scheduled for Tuesday, January 12, 2016 at 7:30 p.m. Eastern Time.
The presentation will be we... |